In another study, Lou C et al. investigated the correlation between NLR, PLR, and HALP (hemoglobin and albumin levels and lymphocyte and platelet counts) for neoadjuvant therapy and prognosis for triple-negative breast cancer. This evidence concerns the gene ALB and triple-negative breast carcinoma.